Summary
Updated Aug 31, 2026
Allen S. Melemed is CHIEF MEDICAL OFFICER of CHIMERIX INC (CMRX). 1 SEC Form 4 filing on record, dated 21 April 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Allen S. Melemed has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Allen S. Melemed go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Allen S. Melemed's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $117.62M of ARTV open-market activity in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
- Michael Simanovsky - $105.88M of SNDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Allen S. Melemed?
Allen S. Melemed is a corporate insider, tracked as CHIEF MEDICAL OFFICER of CHIMERIX INC (CMRX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Allen S. Melemed last file a Form 4?
The only primary Form 4 on record is dated 21 April 2025.
Where can I see all of Allen S. Melemed's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Allen S. Melemed and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial